FDA Approved: PONVORY — Original Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approves PONVORY (ponesimod) from Janssen as the original approval for treatment of adults with relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PONVORY (PONESIMOD)

Snippet

ORIG AP for PONVORY (PONESIMOD)